3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rectal Diseases
1
Neoplasms by Site
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Colorectal Neoplasms
1
Interventions
Bevacizumab
2
trifluridine tipiracil drug combination
1
gadolinium ethoxybenzyl DTPA
1
gadobutrol
1
encorafenib
1
durvalumab
1
Urine Specimen Collection
1
Tomography, X-Ray Computed
1
Surveys and Questionnaires
1
Oxaliplatin
1
Oviposition
1
Nivolumab
1
Levoleucovorin
1
Leucovorin
1
Irinotecan
1
Immunotherapy
1
IDRX-42
1
Hydromorphone
1
Fluorouracil
1
Fentanyl
1
Drug Therapy
1
Drainage
1
Dietary Supplements
1
Colonoscopy
1
Cetuximab
1
Capecitabine
1
Bupivacaine
1
Blood Specimen Collection
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Digestive System Diseases
×
Oviposition
×
1 year
×
Clear all
NCT01269567
2026-05-14
GRECCAR 5
University Hospital, Bordeaux
Phase 3
Completed
494 enrolled